Literature DB >> 18384155

Pharmaceutical aspects of drug eluting stents.

E Deconinck1, J Sohier, I De Scheerder, G Van den Mooter.   

Abstract

This review focuses on the pharmaceutical aspects of the development of drug eluting stents. It discusses the different processes that can be used to obtain a controlled release of a drug from the stent as well as the coatings therefore applied. Results obtained for stents already available on the market or in a far stage of development are discussed. In a final part possible future research areas as well as expected new evolutions in the design of drug eluting stents are presented.

Mesh:

Year:  2008        PMID: 18384155     DOI: 10.1002/jps.21356

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Modeling and analysis of drug-eluting stents with biodegradable PLGA coating: consequences on intravascular drug delivery.

Authors:  Xiaoxiang Zhu; Richard D Braatz
Journal:  J Biomech Eng       Date:  2014-11       Impact factor: 2.097

2.  OPTIMA Tacrolimus-eluting Stent: A Twelve-month Clinical Follow up with Two Different Periods of Dual Antiplatelet Therapy; 2-month vs. 6-month Approach.

Authors:  Nasser Aslanabadi; Ahmad Separham; Reza Beheshti; Samad Ghaffari; Bahram Sohrabi
Journal:  J Cardiovasc Thorac Res       Date:  2012-09-23

Review 3.  Non-polymer drug-eluting coronary stents.

Authors:  Nagavendra Kommineni; Raju Saka; Wahid Khan; Abraham J Domb
Journal:  Drug Deliv Transl Res       Date:  2018-08       Impact factor: 4.617

4.  Modelling intravascular delivery from drug-eluting stents with biodurable coating: investigation of anisotropic vascular drug diffusivity and arterial drug distribution.

Authors:  Xiaoxiang Zhu; Daniel W Pack; Richard D Braatz
Journal:  Comput Methods Biomech Biomed Engin       Date:  2012-04-18       Impact factor: 1.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.